Cytomegalovirus/herpesvirus and carotid atherosclerosis: The aric study
The DOI matches its Crossref record.
Abstract
Ubiquitous viruses such as members of the human herpes virus group, particularly cytomegalovirus (CMV), have been proposed to be clinically important agents in the initiation and progression of atherosclerosis. Antibodies to CMV and herpes simplex virus type 1 (HSV1) and type 2 (HSV2) were determined in 340 matched case‐control pairs from the Atherosclerosis Risk in Communities (ARIC) Study. Cases were defined by B‐mode ultrasonography as persons with thickened carotid artery walls consistent with early atherosclerosis but without a history of cardiovascular disease. Controls were defined as persons without thickened walls or history of cardiovascular disease. The case‐control odds ratio for CMV antibodies was 1.55 (P = 0.03), for HSV 1.41 (P = 0.07), and for HSV2 0.91 (P = .63). When adjustment was made for potential con‐founders, the odds ratios were 1.36 for CMV (P=.24), 1.21 for HSV1 (P = .45), and 0.61 (P = .05) for HSV2. These results suggest a modest association between CMV and asymptomatic carotid wall thickening consistent with early atherosclerosis. © 1994 Wiiey‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Intima–media thickness: a new tool for diagnosis and treatment of cardiovascular risk
Simon, A., Gariepy, J., Chironi, G., Megnien, J.-L., & Levenson, J. (2002) · Journal of Hypertension · doi:10.1097/00004872-200202000-00001 · Cited by 613
Infection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Role of Infection as a Risk Factor for Atherosclerosis, Myocardial Infarction, and Stroke
Mattila, K. J., Valtonen, V. V., Nieminen, M. S., & Asikainen, S. (1998) · Clinical Infectious Diseases · doi:10.1086/514570 · Cited by 309
Nieto, F. J., Adam, E., Sorlie, P., Farzadegan, H., Melnick, J. L., Comstock, G. W., & Szklo, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.922 · Cited by 303
Self-citationEffects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
Zhu, J., Quyyumi, A. A., Norman, J. E., Csako, G., Waclawiw, M. A., Shearer, G. M., & Epstein, S. E. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00653-0 · Cited by 298
Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death
Zhu, J., Nieto, F. J., Horne, B. D., Anderson, J. L., Muhlestein, J. B., & Epstein, S. E. (2001) · Circulation · doi:10.1161/01.cir.103.1.45 · Cited by 279
Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction
Naghavi, M., Barlas, Z., Siadaty, S., Naguib, S., Madjid, M., & Casscells, W. (2000) · Circulation · doi:10.1161/01.cir.102.25.3039 · Cited by 272
Sorlie, P. D., Nieto, F. J., Adam, E., Folsom, A. R., Shahar, E., & Massing, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.2027 · Cited by 170
Self-citationFaerstein, E., Szklo, M., & Rosenshein, N. B. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.1.11 · Cited by 164
“The potential role of infection in UL development can also be postulated in the context of similarities between this tumor and the atheromatous plaque, because of the suggestion that chlamydial and viral infections play a role in atherosclerosis (33, 34 ).”
BackgroundLee, Y.-L., Liu, C.-E., Cho, W.-L., Kuo, C.-L., Cheng, W.-L., Huang, C.-S., & Liu, C.-S. (2014) · Biomarkers · doi:10.3109/1354750x.2013.877967 · Cited by 29
Grąbczewska, Z., Nartowicz, E., Kubica, J., & Rość, D. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.02.005 · Cited by 20
“Although numerous studies have been conducted on infections and atherosclerosis or coronary heart disease, the mechanism of this link remains unclear [2–7].”
Background
Metadata
- Authors
- Sorlie, P. D., Adam, E., Melnick, S. L., Folsom, A., Skelton, T., Chambless, L. E., Barnes, R., & Melnick, J. L.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 1994-01
- Volume
- 42
- Issue
- 1
- Pages
- 33-37
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W1989958005
- Cited by
- 136
- References
- 0
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.